Characteristics of preventive intervention acceptance for international travel among clients aged 60 years and older from a Japanese multicenter pretravel consultation registry

• Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 29; no. 12; pp. 1137 - 1144
• Main Authors: Yamamoto, Kei, Asai, Yusuke, Nakagawa, Hidenori, Nakatani, Issaku, Hayashi, Kenichi, Matono, Takashi, Kanai, Shinichiro, Yamato, Masaya, Mikawa, Takahiro, Shimatani, Michitsugu, Shimono, Nobuyuki, Shinohara, Koh, Kitaura, Tsuyoshi, Nagasaka, Atsushi, Manabe, Akihiro, Komiya, Nobuhiro, Imakita, Natsuko, Yamamoto, Yoshihiro, Iwamoto, Noriko, Okumura, Nobumasa, Ohmagari, Norio
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.12.2023
• Subjects: International travel; Japan; Multicenter registry; Older adults; Pretravel consultation; Travelers' vaccinations; International travel; Multicenter registry; Older adults; Japan; Travelers' vaccinations; Pretravel consultation
• ISSN: 1341-321X; 1437-7780; 1437-7780
• DOI: 10.1016/j.jiac.2023.08.013

Pretravel consultation (PTC) is important for older adults owing to health problems associated with overseas travel. Although older adults in Japan, their PTC characteristics are less known. This study aimed to investigate the epidemiology of clients aged ≥ 60 years based on data from the Japan Pre-travel Consultation Registry (J-PRECOR). Clients aged ≥ 60 years who visited J-PRECOR cooperative hospitals from February 1, 2018, to May 31, 2022, were included. The primary endpoint was a comparison of prescriptions for vaccines for hepatitis A, tetanus toxoid, and malaria prophylaxis in travelers to high-risk malaria countries in yellow fever vaccination (YFV)-available facilities with and without YFV. In total, 1000 clients (median age: 67 years) were included. Although 523 clients were immunized with YFV, only 38.6% of the 961 unimmunized clients were vaccinated with the tetanus toxoid-containing vaccine. Malaria chemoprophylaxis was prescribed to 25.7% of clients traveling for ≤55 days. At YFV-capable institutes, 557 clients traveling to yellow fever risk countries took PTC, 474 of whom received YFV and 83 were unvaccinated. Lower age (odds rate 0.85 per 1 year; 95% CI 0.80–0.90) and lower hepatitis A vaccination rate (0.29; 95% CI 0.14–0.63) were significantly associated with YFV. Preventive interventions other than YFV should be offered to older adults.